abstract |
The present invention relates to novel compounds of formula (I) as nucleocapsid assembly inhibitors for the treatment of viruses, including especially but not exclusively for the treatment of hepatitis B virus (HBV) and novel methods of using said compounds Inhibitors of HBV pregenomic RNA encapsidation in infection and related pathologies. (Formula (I)) includes its hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes, wherein A, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are defined herein. |